Koers Spring Pharmaceutical Group, Inc.
Aandelen
BYC
US84987P1057
Farmaceutische producten
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ting He Yan
CEO | Chief Executive Officer | 69 | 01-01-89 |
Chuan Min Li
DFI | Director of Finance/CFO | 59 | 01-01-05 |
Qiang Zhang
ADM | Chief Administrative Officer | 52 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ting He Yan
CEO | Chief Executive Officer | 69 | 01-01-89 |
Ji Rui Zhang
BRD | Director/Board Member | 68 | 01-01-04 |
Director/Board Member | 73 | 06-04-09 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+56,86% | 815 mld. | |
+43,90% | 641 mld. | |
-6,57% | 352 mld. | |
+17,32% | 314 mld. | |
+9,94% | 303 mld. | |
+16,08% | 242 mld. | |
+2,29% | 224 mld. | |
+13,96% | 218 mld. | |
+7,98% | 168 mld. |